European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
01 6Polpharma
02 3Dr. Reddy's Laboratories
03 92care4
04 20Abacus Medicine
05 4Actavis Inc
06 8Ajanta Pharma Limited
07 4Alembic Pharmaceuticals Limited
08 3Alter Laboratories Sa
09 5Amdipharm Mercury Company Limited
10 4Amneal Pharmaceuticals
11 3Apotex Inc
12 4CLONMEL HLTHCARE
13 4CSPC Pharmaceutical Group
14 3Centocor
15 3Cinfa
16 5Ebb Medical
17 4Eskayef Pharmaceutical
18 12Exeltis
19 6Genericon Pharma Ges.M.B.H.
20 4Helsinn Advanced Synthesis
21 6Heumann
22 8Inventia Healthcare Limited
23 90Janssen-Cilag
24 30Johnson & Johnson Innovative Medicine
25 3Kern Pharma S.L.
26 12Krka
27 5Laboratorios Liconsa
28 4Lupin Ltd
29 3Medartuum
30 8Mepha Pharma
31 12Neuraxpharm
32 1Nordic Prime Aps
33 9ORIFARM GROUP AS
34 3Pantson Pharma Pvt. Limited
35 5Pharmathen SA
36 2RELIANCE FORMULATION PVT. LTD
37 4RK Pharma
38 12STADA Arzneimittel
39 21Sandoz B2B
40 5Spirig Healthcare
41 4Sun Pharmaceutical Industries Limited
42 6TAD Pharma
43 19Teva Pharmaceutical Industries
44 6Uab Bijon Medica
45 4Unichem Laboratories Limited
46 6Vale Pharmaceuticals Ltd
47 12Viatris
48 15Zentiva
49 4Zydus Pharmaceuticals
50 4i3 Pharmaceuticals
51 16Blank
01 1Depot Injection
02 20ER Tablet
03 10Extended Release Tablet
04 9Extended Release Tablets
05 42Extended-Release Tablet
06 4INJ
07 91Injectable Solution
08 3LP Tablet
09 6Modified Release Tablet
10 1Paliperidone 100Mg 1 Unit Parenteral Use Rp
11 1Paliperidone 150Mg 1 Unit Parenteral Use Rp
12 1Paliperidone 3Mg 28 Combined Oral Use Rp
13 1Paliperidone 50Mg 1 Unit Parenteral Use Rp
14 1Paliperidone 6Mg 28 Combined Oral Use Rp
15 1Paliperidone 75Mg 1 Unit Parenteral Use Rp
16 1Paliperidone 9Mg 28 Combined Oral Use Rp
17 6Prolonged Release Suspension For Injection In Pre-Filled Syringe
18 8Prolonged Release Tablet
19 8Prolonged-Release Injectable Suspension
20 19Prolonged-Release Suspension For Injection
21 10Prolonged-Release Tablet
22 97Suspension For Injection
23 3TAB
24 3TABLET (EXTENDED-RELEASE)
25 4TABLET, EXTENDED RELEASE; ORAL
26 63TABLET, EXTENDED RELEASE;ORAL
27 25Tablet
28 14Blank
01 28Allowed
02 168Approved
03 4Authorised
04 36Authorized
05 4Countries Registered In: US (Filed 2012)
06 17DISCN
07 19Deregistered
08 4Generic
09 7Originator
10 3PRESCRIPTION
11 43Prescription
12 42RX
13 12Registered in US
14 4US (Filed 2012)
15 62Blank
01 4Byannli
02 6Dnepr
03 16INVEGA
04 3Inpalix
05 34Invega
06 1Invega 3Mg
07 1Invega 6Mg
08 1Invega 9Mg
09 2Invega Hafyera
10 5Invega Sustenna
11 4Invega Trinza
12 6Invega®
13 9Mopetia
14 12Niapelf
15 1PALICALM ER 3
16 1PALICALM ER 6
17 3PALIPERIDON KRKA
18 58PALIPERIDONE
19 3PALIPERIDONE SANDOZ
20 3PALIPERIDONE TEVA
21 6Paliperidon Heumann
22 6Paliperidon Krka
23 36Paliperidon Teva
24 6Paliperidon Zentiva
25 1Paliperidon "2Care4"
26 1Paliperidon "Abacus Medicine"
27 3Paliperidon "Krka"
28 1Paliperidon "Nordic Prime"
29 3Paliperidona Cinfa
30 3Paliperidona Ratiopharm
31 3Paliperidona Sandoz
32 4Paliperidone 2Care4
33 3Paliperidone Alter
34 6Paliperidone Bijon
35 4Paliperidone Clonmel
36 3Paliperidone Ebb
37 6Paliperidone Exeltis
38 6Paliperidone Genericon
39 6Paliperidone Janssen
40 6Paliperidone Janssen-Cilag International
41 5Paliperidone Liconsa
42 9Paliperidone Sandoz
43 1Paliperidone Spirig HC retard
44 4Paliperidone Spirig HC retard
45 6Paliperidone Stada
46 3Paliperidone Tad
47 4Paliperidone Teva
48 6Paliperidone Vale
49 6Paliperidone Viatris
50 6Paliperidone Viatris Pharma
51 1Paliperidone-Mepha
52 4Paliperidone-Mepha im
53 3Paliperidone-Mepha retard
54 9Palmeux
55 6Parnido
56 6Poltraxin
57 6Pratyria
58 6Psylipax
59 3Teva Paliperidon
60 8Trevicta
61 4Trevicta
62 1XEPLION 100 mg/1,0 ml
63 1XEPLION 150 mg/1,50 ml
64 1XEPLION 50 mg/0,50 ml
65 1XEPLION 75 mg/0,75 ml
66 21Xeplion
67 4Xeplion®
68 32Blank
01 14Australia
02 3Canada
03 11Denmark
04 32Estonia
05 5Greece
06 25India
07 20Italy
08 4Malta
09 10Moldova
10 7South Africa
11 36Spain
12 187Sweden
13 28Switzerland
14 67USA
15 4Blank
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 25mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 50mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 75mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg, 150mg
Packaging :
Approval Date : 04-07-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Paliperidone Ebb
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date : 30-01-2019
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Invega
Dosage Form : Tablet
Dosage Strength : 12mg
Packaging :
Approval Date : 25-06-2007
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Invega
Dosage Form : Tablet
Dosage Strength : 1.5mg
Packaging :
Approval Date : 12-01-2009
Application Number : 2.01E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-26
Application Number : 21999
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidon Krka
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date : 18-05-2018
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidon Krka
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date : 18-05-2018
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidon Krka
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date : 18-05-2018
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
